{"id":1618,"date":"2022-12-15T10:04:41","date_gmt":"2022-12-15T10:04:41","guid":{"rendered":"https:\/\/avaeh.org\/web_nueva_2021\/?p=1618"},"modified":"2022-12-15T10:04:41","modified_gmt":"2022-12-15T10:04:41","slug":"caracterizacion-farmacologica-de-los-fitocannabinoides-y-el-sistema-endocannabinoide-en-neurodegenerativas","status":"publish","type":"post","link":"https:\/\/avaeh.org\/web_nueva_2021\/2022\/12\/15\/caracterizacion-farmacologica-de-los-fitocannabinoides-y-el-sistema-endocannabinoide-en-neurodegenerativas\/","title":{"rendered":"Caracterizaci\u00f3n farmacol\u00f3gica de los fitocannabinoides y el sistema endocannabinoide (en neurodegenerativas)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">\u00abEn diciembre de 2021, InMed present\u00f3 una solicitud de patente internacional que demuestra la neuroprotecci\u00f3n y la funci\u00f3n neuronal mejorada utilizando cannabinoides y an\u00e1logos raros para el tratamiento potencial de enfermedades neurodegenerativas como la enfermedad de Alzheimer, la enfermedad de Parkinson, la enfermedad de Huntington y otras.\u00a0La patente especifica los compuestos que pueden inhibir o retrasar la progresi\u00f3n de las enfermedades neurodegenerativas proporcionando neuroprotecci\u00f3n en una poblaci\u00f3n de neuronas afectadas.\u00bb<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/11\/16\/2557041\/36215\/en\/InMed-Pharmaceuticals-Advances-Neurodegenerative-Disease-Program-with-Natural-Sciences-and-Engineering-Research-Council-of-Canada-NSERC-Alliance-Grant-Funding.html?utm_content=buffer81ba8&amp;utm_medium=social&amp;utm_source=bufferapp.com&amp;utm_campaign=buffer\" target=\"_blank\" rel=\"noreferrer noopener\">LINK A LA NOTICIA COMPLETA<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00abEn diciembre de 2021, InMed present\u00f3 una solicitud de patente internacional que demuestra la neuroprotecci\u00f3n y la funci\u00f3n neuronal mejorada utilizando cannabinoides y an\u00e1logos raros para el tratamiento potencial de enfermedades neurodegenerativas como la enfermedad de Alzheimer, la enfermedad de Parkinson, la enfermedad de Huntington y otras.\u00a0La patente especifica los [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7,6,453,4,9,452,5,450,58,451,8],"class_list":["post-1618","post","type-post","status-publish","format-standard","hentry","category-sin-categoria","tag-asociacion-valenciana-de-enfermedad-de-huntington","tag-avaeh","tag-endocannabinoide","tag-enfermedad-de-huntington","tag-enfermedades-raras","tag-fitocannabinoides","tag-huntingtons-disease","tag-inmed","tag-neurodegenerativa","tag-neuroproteccion","tag-rare-diseases"],"_links":{"self":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/1618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/comments?post=1618"}],"version-history":[{"count":1,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/1618\/revisions"}],"predecessor-version":[{"id":1619,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/posts\/1618\/revisions\/1619"}],"wp:attachment":[{"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/media?parent=1618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/categories?post=1618"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avaeh.org\/web_nueva_2021\/wp-json\/wp\/v2\/tags?post=1618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}